These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18186527)

  • 41. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report.
    Nakamura Y; Matsuno N; Iwamoto H; Yokoyama T; Kuzuoka K; Kihara Y; Taira S; Sagara T; Jojima Y; Konno O; Tashiro J; Akashi I; Hama K; Narumi K; Iwahori T; Uchiyama M; Tanaka K; Nagao T
    Transplant Proc; 2004 Oct; 36(8):2269-73. PubMed ID: 15561215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current progress in ABO-incompatible liver transplantation.
    Tanabe M; Kawachi S; Obara H; Shinoda M; Hibi T; Kitagawa Y; Wakabayashi G; Shimazu M; Kitajima M
    Eur J Clin Invest; 2010 Oct; 40(10):943-9. PubMed ID: 20636381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABO-incompatible liver transplantation: a new therapeutic option for patients with acute liver failure in Chile.
    Uribe M; Buckel E; Ferrario M; Segovia R; González G; Hunter B; Godoy J; Berwart F; Brahm J; Silva G; Cavallieri S; Calabrán L; Santander MT; Herzog C
    Transplant Proc; 2005 Apr; 37(3):1567-8. PubMed ID: 15866675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ABO-incompatible liver transplantation for critically ill adult patients.
    Toso C; Al-Qahtani M; Alsaif FA; Bigam DL; Meeberg GA; James Shapiro AM; Bain VG; Kneteman NM
    Transpl Int; 2007 Aug; 20(8):675-81. PubMed ID: 17521384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
    Yoshizawa A; Sakamoto S; Ogawa K; Kasahara M; Uryuhara K; Oike F; Ueda M; Takada Y; Egawa H; Tanaka K
    Transplant Proc; 2005 May; 37(4):1718-9. PubMed ID: 15919443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful rescue of refractory, severe antibody mediated rejection with splenectomy.
    Kaplan B; Gangemi A; Thielke J; Oberholzer J; Sankary H; Benedetti E
    Transplantation; 2007 Jan; 83(1):99-100. PubMed ID: 17220802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L; Mazzoni A; Colombatto P; Bindi L; Biancofiore G; Tascini C; Menichetti F; Brunetto MR; Scatena F; Filipponi F
    Transplantation; 2008 Dec; 86(12):1666-71. PubMed ID: 19104402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status of ABO-incompatible kidney transplantation in children.
    Shishido S; Hasegawa A
    Pediatr Transplant; 2005 Apr; 9(2):148-54. PubMed ID: 15787785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study.
    Mendes M; Ferreira AC; Ferreira A; Remédio F; Aires I; Cordeiro A; Mascarenhas A; Martins A; Pereira P; Gloria H; Perdigoto R; Veloso J; Ferreira P; Oliveira J; Silva M; Barroso E; Nolasco F
    Transplant Proc; 2013 Apr; 45(3):1110-5. PubMed ID: 23622639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.
    Lehrich RW; Rocha PN; Reinsmoen N; Greenberg A; Butterly DW; Howell DN; Smith SR
    Hum Immunol; 2005 Apr; 66(4):350-8. PubMed ID: 15866697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure.
    Shen T; Lin BY; Jia JJ; Wang ZY; Wang L; Ling Q; Geng L; Yan S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):395-401. PubMed ID: 25100124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation.
    Allen G; Simpkins CE; Segev D; Warren D; King K; Taube J; Locke J; Baldwin W; Haas M; Chivukula R; Montgomery RA
    Contrib Nephrol; 2009; 162():35-46. PubMed ID: 19001812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic?
    Lawrence C; Galliford JW; Willicombe MK; McLean AG; Lesabe M; Rowan F; Papalois V; Regan F; Taube D
    Transplantation; 2011 Nov; 92(10):1129-33. PubMed ID: 21959216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ABO incompatible renal transplantation: a paradigm ready for broad implementation.
    Montgomery RA; Locke JE; King KE; Segev DL; Warren DS; Kraus ES; Cooper M; Simpkins CE; Singer AL; Stewart ZA; Melancon JK; Ratner L; Zachary AA; Haas M
    Transplantation; 2009 Apr; 87(8):1246-55. PubMed ID: 19384174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
    Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term outcome of ABO-incompatible living-donor liver transplantation: a single-center experience.
    Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Satomi S
    J Hepatobiliary Pancreat Surg; 2009; 16(4):468-72. PubMed ID: 19333538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers.
    Demetris AJ; Jaffe R; Tzakis A; Ramsey G; Todo S; Belle S; Esquivel C; Shapiro R; Markus B; Mroczek E
    Am J Pathol; 1988 Sep; 132(3):489-502. PubMed ID: 3046369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel approach to successful ABO-incompatible high-titer renal transplantation.
    Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T
    Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.